Skip to main content
. Author manuscript; available in PMC: 2022 Oct 13.
Published in final edited form as: Exp Clin Psychopharmacol. 2019 Mar 28;27(6):536–551. doi: 10.1037/pha0000278

Table 1.

Prequit baseline demographics by group.

Delayed Quit Placebo Bupropion SR NRT

Comp. 18 Drops 02 Abstain 25 Relapse 10 Abstain 24 Relapse 10 Abstain 28 Relapse 10
Age 27.2
(10.9)
23.0
(4.2)
32.8
(11.5)
28.2
(6.7)
32.8
(12.4)
28.2
(10.1)
31.5
(11.3)
28.2
(10.1)
Gender 10M, 8F 2M, 0F 13M, 12F 4M, 6F 14M, 10F 6M, 4F 16M, 12F 4M, 6F
Ethnicity AA-1
AI-0
Asn-1
Cau-14
Other-2
AA-0
AI-0
Asn-0
Cau-2
Other-0
AA-0
AI-0
Asn-1
Cau-24
Other-0
AA-0
AI-0
Asn-0
Cau-10
Other-0
AA-2
AI-0
Asn-0
Cau-19
Other-3
AA-1
AI-1
As-0
Cau-8
Other-0
AA-0
AI-0
Asn-0
Cau-27
Other-1
AA-1
AI-0
Asn-0
Cau-9
Other-0
Hispanic 1 0 2 0 1 0 1 1
Education 3.78
(1.35)
3.50
(0.71)
4.32
(1.46)
3.50
(0.85)
4.00
(1.77)
3.40
(1.75)
3.82
(1.52)
3.40
(1.43)
Age first smoked daily* 18.28
(4.23)
15.00
(4.24)
17.84
(2.59)
17.40
(2.17)
17.75
(3.47)
16.20
(1.75)
17.68
(3.33)
15.3
(2.75)
FTND 3.78
(2.34)
4.50
(0.71)
3.44
(1.94)
5.50
(1.72)
4.29
(1.14)
4.50
(2.42)
4.25
(2.19)
4.10
(1.79)
CPD 18.06
(6.38)
16.00
(4.25)
16.56
(6.04)
20.70
(1.90)
19.25
(9.23)
15.5
(4.97)
17.79
(7.18)
17.50
(5.48)
Cotinine 5.86
(.41)
6.0
(0.0)
5.92
(.28)
6.0
(.0)
6.0
(.0)
6.0
(.0)
5.95
(.21)
6.0
(.0)
Hx of Depress. 1 1 6 4 7 0 8 3
Hx of Anxiety Disorder 5 1 5 2 5 1 10 3
Hx of PTSD 5 0 4 3 3 0 8 2

Note. Means, standard deviations (in parentheses), and Counts: Education: 1= HS equivalency exam, 2=Completed HS, 3= Some College, 4=Associates degree; 5=4-yr degree; 6=Some Grad school; 7=Completed Grad School. Cotinine: 4= 200–500 ng/ml, 5 = 500–1000 ng/ml and 6 = over 1000 ng/ml urine concentrations. Ethnicity (self-reported): AA = African American, AI= American Indian, Asn=Asian, Cau = Caucasian, Oth = Other or mixed.

*

p <.05 completers = older age of daily smoking onset than relapsers. Hx = history of SCID-assessed major depressive disorder, anxiety disorder, or post-traumatic stress disorder.